- Home
- PGC vs SEPN Comparison
PGC vs SEPN Comparison
Compare PGC & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGC
- SEPN
- Stock Information
- Founded
- PGC 1921
- SEPN 2022
- Country
- PGC United States
- SEPN United States
- Employees
- PGC N/A
- SEPN N/A
- Industry
- PGC Commercial Banks
- SEPN
- Sector
- PGC Finance
- SEPN
- Exchange
- PGC Nasdaq
- SEPN NYSE
- Market Cap
- PGC 562.0M
- SEPN 631.0M
- IPO Year
- PGC N/A
- SEPN 2024
- Fundamental
- Price
- PGC $32.65
- SEPN $5.80
- Analyst Decision
- PGC Buy
- SEPN Buy
- Analyst Count
- PGC 1
- SEPN 4
- Target Price
- PGC $44.00
- SEPN $34.00
- AVG Volume (30 Days)
- PGC 85.2K
- SEPN 857.5K
- Earning Date
- PGC 01-28-2025
- SEPN 02-28-2025
- Dividend Yield
- PGC 0.61%
- SEPN N/A
- EPS Growth
- PGC N/A
- SEPN N/A
- EPS
- PGC 1.85
- SEPN N/A
- Revenue
- PGC $220,628,000.00
- SEPN $981,000.00
- Revenue This Year
- PGC N/A
- SEPN $406.62
- Revenue Next Year
- PGC $15.51
- SEPN N/A
- P/E Ratio
- PGC $17.65
- SEPN N/A
- Revenue Growth
- PGC 2.36
- SEPN N/A
- 52 Week Low
- PGC $20.30
- SEPN $4.17
- 52 Week High
- PGC $37.88
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- PGC 45.38
- SEPN N/A
- Support Level
- PGC $32.54
- SEPN N/A
- Resistance Level
- PGC $35.41
- SEPN N/A
- Average True Range (ATR)
- PGC 1.49
- SEPN 0.00
- MACD
- PGC -0.05
- SEPN 0.00
- Stochastic Oscillator
- PGC 48.89
- SEPN 0.00
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Peapack Private Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and internet banking services. Peapack Private includes asset management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.